- Article
- Source: Campus Sanofi
- 4 Jun 2025
Transform Myeloma
While patients often prefer oral administration, common regimens include a combination of oral and non-oral treatments.1
Manual subcutaneous injection is fast, but can be physically demanding to
administer.
IV delivery is familiar—but in some cases requires longer chair time and
monitoring.
Subcutaneous syringe pump is hands-free, yet may introduce logistical
complexity to set up.
Treatment administration can weigh
heavy on everyone.
Consider how multiple myeloma treatment
administration may be impacting your
patients
Have any of your patients with multiple myeloma reported pain or discomfort from treatment administration?
Studies show that treatment administration
can cause some pain or discomfort¹⁰–¹²
Patients receiving IV infusions may experience pain related to cannulation, while in subcutaneous administration, larger needle diameters have been linked to increased pain and bruising at the injection site.¹⁰–¹²
Multiple myeloma treatment administration burdens can extend from patients to providers.
Have your nurses shared how
their experiences differ across administration options?
their experiences differ across administration options?
The weight of treatment administration can add up and disrupt daily workflow, placing a
strain on your practice.
MAT-SA-2600306